期刊文献+

FQ-PCR检测胃癌患者外周血C-erbB-2 mRNA的表达及其临床意义

Expression and clinical significance of C-erbB-2 mRNA expression in peripheral blood of patients with gastric cancer
原文传递
导出
摘要 目的探讨原癌基因人表皮生长因子2(C-erbB-2)在胃癌患者外周血中的mRNA表达,并评价其在诊断胃癌患者外周血微转移及与临床病理因素的相关性和意义。方法采用实时荧光定量PCR(FQ-PCR)法检测56例经病理学确诊的胃癌患者、20例慢性胃炎患者和30例健康对照者外周血C-erbB-2和内参基因3-磷酸甘油醛脱氢酶(GAPDH)的表达水平,分析组间相对表达水平(C-erbB-2/GAPDH)的差异及与临床病理因素的关系。结果胃癌组C-erbB-2 mRNA阳性表达率高于慢性胃炎和健康对照组(26.8%vs.0%和0%)(P<0.01)。阳性表达率与患者年龄、性别无关,而与肿瘤分化程度、有无淋巴结转移、TNM分期和浸润深度相关(P<0.05或P<0.01)。结论检测胃癌患者外周血中C-erbB-2 mRNA的表达对诊断早期胃癌及微转移状况是一种敏感且特异的方法。 Objective To explore the expression level of human epidermal growth factor-2(C-erb-B2) mRNA in peripheral blood of patients with gastric cancer and evaluate its clinical value in diagnosing the micro-metastatic status and its correlation with clinicopathological parameters.MethodsFQ-PCR was used to determine the expression level of C-erbB-2 mRNA and glyceraldehyde-3-phosphate dehydrogenase(GAPDH) mRNA in peripheral blood of 56 cases with gastric cancer(group A),20 cases with chronic gastritis(group B) and 30 healthy volunteers(group C).ResultsThe positive expression rate of group A was significantly higher than that of group B or group C(26.8% vs.0% or 0%)(P0.01),which was correlated to state of differentiation,lymph node metastasis,clinical TNM stage,and depth of invasion(P0.05 or P0.01) but not correlated to age and gender.ConclusionDetecting the expression level of C-erbB-2 mRNA in peripheral blood of patients with gastric cancer is a sensitive and specific method for diagnosing the early stage of tumor and micro-metastasis.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第1期86-89,共4页 Jiangsu Medical Journal
关键词 胃癌 人表皮生长因子2 Gastric cancer Human epidermal growth factor-2
  • 相关文献

参考文献13

  • 1吴阶平 裘法祖.黄家驷外科学[M]第6版[M].北京:人民卫生出版社,2000.2126-2133.
  • 2Ikeguchi M, Ohro S, Maeda Y, et al . Detection of cancer cells in the peripheral blood of gastric cancer patients[J], Int J Mol Med,2003,11(2) :217-221.
  • 3Castello R, Estelles A, Vazquez C, et al. Quantitative realtime PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type I , and tissue metalloproteinase inhibitor type I gene expressions in primary breast cancer [J]. Clin Chem,2002,48(8) : 1288-1295.
  • 4Riese DJ, Stem DF. Specificity within the EFG family/ErbB recepor family signaling network[J]. Bioessay, 1998, 20 ( 1 ) : 41-48.
  • 5Korrapati V,Gaffney M,Larsson LG,et al. Effect of HER2/ neu expression on survival in non-small cell lung cance[J]. Clin Lung Cancer, 2001,2 (3) : 216-219.
  • 6Demirbas S, Stictillti I, Yildirim S, et al. Influence of the c-erbB-2,nm23, bcl-2 and p53 protein markers on colorectal cancer[J]. Turk J Gastroenterol, 2006,17 (1) : 13 -19.
  • 7Hynes NE. Tyrosine kinase signaling in breast cancer[J]. Breast Cancer Res, 2000,2(3) : 154-157.
  • 8陆辉,王水,夏添松.240例乳腺癌组织中p53、C-erbB-2表达的临床分析[J].江苏医药,2007,33(8):790-791. 被引量:10
  • 9Menard S,Casalini P,Campiglio M, et al. HER2 overexpression in various tumor types, focusing on its relationship to the development of invasive breast cancer[J]. Ann Oncol, 2001, 12 (Suppl 1) : 15-19.
  • 10Canoz O, Ozkan M, Arsav V, et al. The role of c-erbB-2 expression on the survival of patients with small-cell lung cancer[J].Lung, 2006,184(5) : 267-272.

二级参考文献19

  • 1LiZHENG JiaQiangREN HuaLI ZhaoLuKONG HongGuangZHU.Downregulation of wild-type p53 protein by HER-2/neu mediated PI3K pathway activation in human breast cancer cells: its effect on cell proliferation and implication for therapy[J].Cell Research,2004,14(6):497-506. 被引量:8
  • 2杜长征,李惠平,马力文,付卫,王墨培,贾廷珍,赵红梅,侯宽永.中国乳腺癌患者p53表达临床生物学意义的Meta分析[J].中国癌症杂志,2005,15(6):514-517. 被引量:23
  • 3杜长征,李惠平,侯宽永,李强,赵红梅,王墨培.中国乳腺癌妇女表皮生长因子受体-2表达的Meta分析[J].北京大学学报(医学版),2006,38(2):184-188. 被引量:16
  • 4Moghal N, Sternberg PW. Multiple positive and negative regulators of signaling by the EGF-receptor[J]. Current Opinion in Cell Biology, 1999,11(2) : 190 -196.
  • 5Schechter AL, Hung MC, Vaidyanathan L. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor[J].Science, 1985, 229 (4717): 976-978.
  • 6Menard S, Casalini P, Campiglio M, et al. HER2 overexpression in various tumor types, focusing on its relationship to the development of invasive breast cancer[J].Ann Oncol, 2001,12 (Suppl 1): 15-19.
  • 7Dursun A, Poyraz A, Celik B, et al. Expression of C-erbB-2 oncoprotein in gastric carcinoma: correlation with histopathologic characteristics and analysis of Ki-67 [J]. Pathol Oncol Res, 1999,5(2) : 104-106.
  • 8Takehana T, Kunitomo K, Kono K, et al. Status of C-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzymelinked immuno-sorhent assay[J].Int J Cancer,2002,98(6): 833-837.
  • 9Vizoso F J, Corte MD, Alvarez A, et al. Membranous levels of C-erbB-2 oncoprotein in gastric cancer: their relationship with clinicopathological parameters and their prognostic significance[J]. Int J Biol Markers, 2004,19 (4):268-274.
  • 10Kim MA,Jung EJ, Lee HS, et al. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction[J].Hum Pathol, 2007,38(9) : 1386- 1393.

共引文献179

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部